Literature DB >> 22253469

Circulating invariant natural killer T-cell numbers predict outcome in head and neck squamous cell carcinoma: updated analysis with 10-year follow-up.

Famke L Schneiders, Renée C G de Bruin, Alfons J M van den Eertwegh, Rik J Scheper, C René Leemans, Ruud H Brakenhoff, Johannes A Langendijk, Henk M W Verheul, Tanja D de Gruijl, Johan W Molling, Hans J van der Vliet.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22253469     DOI： 10.1200/JCO.2011.38.8819

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  25 in total

1.  iNKT cell cytotoxic responses control T-lymphoma growth in vitro and in vivo .

Authors:  Hamid Bassiri; Rupali Das; Peng Guan; David M Barrett; Patrick J Brennan; Pinaki P Banerjee; Susan J Wiener; Jordan S Orange; Michael B Brenner; Stephan A Grupp; Kim E Nichols
Journal:  Cancer Immunol Res       Date:  2014-01       Impact factor: 11.151

2.  Vγ9Vδ2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy.

Authors:  Inge M Werter; Famke L Schneiders; Emmanuel Scotet; Henk M W Verheul; Tanja D de Gruijl; Hans J van der Vliet
Journal:  Oncoimmunology       Date:  2014-12-08       Impact factor: 8.110

Review 3.  Engaging Natural Killer T Cells as 'Universal Helpers' for Vaccination.

Authors:  Mary Speir; Ian F Hermans; Robert Weinkove
Journal:  Drugs       Date:  2017-01       Impact factor: 9.546

4.  T cell receptor-engineered T cells to treat solid tumors: T cell processing toward optimal T cell fitness.

Authors:  Cor H J Lamers; Sabine van Steenbergen-Langeveld; Mandy van Brakel; Corrien M Groot-van Ruijven; Pascal M M L van Elzakker; Brigitte van Krimpen; Stefan Sleijfer; Reno Debets
Journal:  Hum Gene Ther Methods       Date:  2014-12       Impact factor: 2.396

Review 5.  The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.

Authors:  Daniela Bruni; Helen K Angell; Jérôme Galon
Journal:  Nat Rev Cancer       Date:  2020-08-04       Impact factor: 60.716

6.  Development of a qPCR method to rapidly assess the function of NKT cells.

Authors:  Silke Sohn; Irina Tiper; Emily Japp; Wenji Sun; Katherine Tkaczuk; Tonya J Webb
Journal:  J Immunol Methods       Date:  2014-04-12       Impact factor: 2.303

7.  Generation and characterization of CD1d-specific single-domain antibodies with distinct functional features.

Authors:  Roeland Lameris; Renée C G de Bruin; Paul M P van Bergen En Henegouwen; Henk M Verheul; Sonja Zweegman; Tanja D de Gruijl; Hans J van der Vliet
Journal:  Immunology       Date:  2016-09       Impact factor: 7.397

Review 8.  Invariant natural killer T cells in hematopoietic stem cell transplantation: killer choice for natural suppression.

Authors:  P Guan; H Bassiri; N P Patel; K E Nichols; R Das
Journal:  Bone Marrow Transplant       Date:  2016-02-15       Impact factor: 5.174

9.  CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses.

Authors:  Stéphanie Corgnac; Rachel Perret; Laurent Derré; Lianjun Zhang; Kathrin Stirnemann; Maurice Zauderer; Daniel E Speiser; Jean-Pierre Mach; Pedro Romero; Alena Donda
Journal:  Cancer Immunol Immunother       Date:  2012-12-15       Impact factor: 6.968

Review 10.  Immune deserts in head and neck squamous cell carcinoma: A review of challenges and opportunities for modulating the tumor immune microenvironment.

Authors:  Janice L Farlow; J Chad Brenner; Yu L Lei; Steven B Chinn
Journal:  Oral Oncol       Date:  2021-07-01       Impact factor: 5.972
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.